Citi Starts Regeneron Pharma (REGN) at Buy, $68 Price Target
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $803.48 -0.31%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
An analyst at Citi initiated coverage on shares of Regeneron Pharma (NASDAQ: REGN) with a Buy rating and a $68 price target Wednesday morning.
Based on Tuesday night's closing price of $47.80, Citi's new price target implies potential upside of about 42 percent.
For more ratings news on Regeneron Pharma click here and for the rating history of Regeneron Pharma click here.
Based on Tuesday night's closing price of $47.80, Citi's new price target implies potential upside of about 42 percent.
For more ratings news on Regeneron Pharma click here and for the rating history of Regeneron Pharma click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Starts Luxshare Precision (2475:HK) at Buy
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
- Piper Sandler Starts Dave Inc (DAVE) at Overweight
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
